SUPN logo

Supernus Pharmaceuticals, Inc. (SUPN) Cash From Investing

Annual CFI:

-$189.87M-$458.60M(-170.65%)
December 31, 2024

Summary

  • As of today, SUPN annual cash from investing is -$189.87 million, with the most recent change of -$458.60 million (-170.65%) on December 31, 2024.
  • During the last 3 years, SUPN annual cash from investing has fallen by -$107.95 million (-131.79%).
  • SUPN annual cash from investing is now -170.65% below its all-time high of $268.73 million, reached on December 31, 2023.

Performance

SUPN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNcash flow metrics

Quarterly CFI:

-$30.61M-$67.92M(-182.02%)
June 30, 2025

Summary

  • As of today, SUPN quarterly cash from investing is -$30.61 million, with the most recent change of -$67.92 million (-182.02%) on June 30, 2025.
  • Over the past year, SUPN quarterly cash from investing has increased by +$17.99 million (+37.01%).
  • SUPN quarterly cash from investing is now -112.76% below its all-time high of $239.78 million, reached on March 31, 2023.

Performance

SUPN Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNcash flow metrics

TTM CFI:

-$82.94M+$17.99M(+17.82%)
June 30, 2025

Summary

  • As of today, SUPN TTM cash from investing is -$82.94 million, with the most recent change of +$17.99 million (+17.82%) on June 30, 2025.
  • Over the past year, SUPN TTM cash from investing has increased by +$48.63 million (+36.96%).
  • SUPN TTM cash from investing is now -129.01% below its all-time high of $285.94 million, reached on September 30, 2023.

Performance

SUPN TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

SUPN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-170.7%+37.0%+37.0%
3Y3 Years-131.8%-95.2%-444.2%
5Y5 Years-20.2%+71.7%-28.4%

SUPN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-170.7%+12.4%-112.8%+62.8%-129.0%+65.9%
5Y5-Year-170.7%+12.4%-112.8%+62.8%-129.0%+65.9%
All-TimeAll-Time-170.7%+54.1%-112.8%+92.8%-129.0%+83.8%

SUPN Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$30.61M(-182.0%)
-$82.94M(+17.8%)
Mar 2025
-
$37.32M(+395.3%)
-$100.93M(+46.8%)
Dec 2024
-$189.87M(-170.7%)
-$12.64M(+83.6%)
-$189.87M(+21.9%)
Sep 2024
-
-$77.01M(-58.5%)
-$243.21M(-84.9%)
Jun 2024
-
-$48.59M(+5.9%)
-$131.56M(-480.2%)
Mar 2024
-
-$51.62M(+21.8%)
-$22.68M(-108.4%)
Dec 2023
$268.73M(+224.0%)
-$65.98M(-290.5%)
$268.73M(-6.0%)
Sep 2023
-
$34.63M(-42.6%)
$285.94M(+69.1%)
Jun 2023
-
$60.30M(-74.9%)
$169.08M(+81.6%)
Mar 2023
-
$239.78M(+591.7%)
$93.10M(+143.0%)
Dec 2022
-$216.66M(-164.5%)
-$48.77M(+40.7%)
-$216.66M(-136.1%)
Sep 2022
-
-$82.23M(-424.5%)
-$91.77M(-502.2%)
Jun 2022
-
-$15.68M(+77.6%)
-$15.24M(+81.1%)
Mar 2022
-
-$69.99M(-191.9%)
-$80.45M(+1.8%)
Dec 2021
-$81.91M(-136.1%)
$76.13M(+1434.7%)
-$81.91M(+24.6%)
Sep 2021
-
-$5.70M(+92.9%)
-$108.70M(+4.9%)
Jun 2021
-
-$80.89M(-13.2%)
-$114.30M(+19.3%)
Mar 2021
-
-$71.44M(-244.8%)
-$141.58M(-308.0%)
Dec 2020
-$34.70M(+78.0%)
$49.34M(+536.6%)
-$34.70M(+46.3%)
Sep 2020
-
-$11.30M(+89.6%)
-$64.61M(-4.8%)
Jun 2020
-
-$108.18M(-405.3%)
-$61.66M(-220.5%)
Mar 2020
-
$35.44M(+82.3%)
-$19.24M(+87.8%)
Dec 2019
-$157.92M(+61.8%)
$19.44M(+332.7%)
-$157.92M(-10.4%)
Sep 2019
-
-$8.36M(+87.3%)
-$143.03M(-30.8%)
Jun 2019
-
-$65.76M(+36.3%)
-$109.34M(+76.5%)
Mar 2019
-
-$103.25M(-400.7%)
-$465.72M(-12.6%)
Dec 2018
-$413.48M(-378.5%)
$34.33M(+35.5%)
-$413.48M(+11.4%)
Sep 2018
-
$25.34M(+106.0%)
-$466.94M(+9.1%)
Jun 2018
-
-$422.14M(-727.6%)
-$513.44M(-340.1%)
Mar 2018
-
-$51.01M(-166.7%)
-$116.66M(-35.0%)
Dec 2017
-$86.42M
-$19.13M(+9.6%)
-$86.42M(-6.8%)
DateAnnualQuarterlyTTM
Sep 2017
-
-$21.16M(+16.6%)
-$80.93M(-15.4%)
Jun 2017
-
-$25.36M(-22.2%)
-$70.12M(-52.2%)
Mar 2017
-
-$20.76M(-52.2%)
-$46.08M(-28.1%)
Dec 2016
-$35.96M(+8.5%)
-$13.64M(-31.8%)
-$35.96M(+6.0%)
Sep 2016
-
-$10.35M(-682.9%)
-$38.25M(-13.8%)
Jun 2016
-
-$1.32M(+87.6%)
-$33.60M(+13.4%)
Mar 2016
-
-$10.65M(+33.1%)
-$38.82M(+1.2%)
Dec 2015
-$39.29M(-1377.6%)
-$15.93M(-179.6%)
-$39.29M(-22.6%)
Sep 2015
-
-$5.70M(+12.9%)
-$32.04M(-17.3%)
Jun 2015
-
-$6.54M(+41.2%)
-$27.32M(-90.0%)
Mar 2015
-
-$11.12M(-28.1%)
-$14.38M(-194.2%)
Dec 2014
-$2.66M(+78.0%)
-$8.68M(-792.5%)
-$4.89M(-119.8%)
Sep 2014
-
-$973.00K(-115.2%)
$24.71M(-18.4%)
Jun 2014
-
$6.40M(+492.8%)
$30.29M(+385.9%)
Mar 2014
-
-$1.63M(-107.8%)
-$10.59M(+12.5%)
Dec 2013
-$12.11M(+75.3%)
$20.91M(+354.0%)
-$12.11M(+71.4%)
Sep 2013
-
$4.61M(+113.4%)
-$42.37M(+26.0%)
Jun 2013
-
-$34.48M(-994.9%)
-$57.28M(-87.5%)
Mar 2013
-
-$3.15M(+66.3%)
-$30.55M(+37.6%)
Dec 2012
-$48.96M(-244.4%)
-$9.35M(+9.3%)
-$48.96M(-245.2%)
Sep 2012
-
-$10.30M(-32.8%)
-$14.18M(-319.4%)
Jun 2012
-
-$7.76M(+64.0%)
$6.46M(-64.2%)
Mar 2012
-
-$21.55M(-184.8%)
$18.05M(-46.8%)
Dec 2011
$33.90M(+31.3%)
$25.43M(+145.9%)
$33.90M(+300.2%)
Sep 2011
-
$10.34M(+170.0%)
$8.47M(+552.8%)
Jun 2011
-
$3.83M(+167.2%)
-$1.87M(+67.2%)
Mar 2011
-
-$5.70M
-$5.70M
Dec 2010
$25.82M(+191.0%)
-
-
Dec 2009
-$28.39M(-283.4%)
-
-
Dec 2008
$15.48M(+4.2%)
-
-
Dec 2007
$14.85M
-
-

FAQ

  • What is Supernus Pharmaceuticals, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. annual cash from investing year-on-year change?
  • What is Supernus Pharmaceuticals, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
  • What is Supernus Pharmaceuticals, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

What is Supernus Pharmaceuticals, Inc. annual cash from investing?

The current annual cash from investing of SUPN is -$189.87M

What is the all-time high annual cash from investing for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high annual cash from investing is $268.73M

What is Supernus Pharmaceuticals, Inc. annual cash from investing year-on-year change?

Over the past year, SUPN annual cash from investing has changed by -$458.60M (-170.65%)

What is Supernus Pharmaceuticals, Inc. quarterly cash from investing?

The current quarterly cash from investing of SUPN is -$30.61M

What is the all-time high quarterly cash from investing for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high quarterly cash from investing is $239.78M

What is Supernus Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?

Over the past year, SUPN quarterly cash from investing has changed by +$17.99M (+37.01%)

What is Supernus Pharmaceuticals, Inc. TTM cash from investing?

The current TTM cash from investing of SUPN is -$82.94M

What is the all-time high TTM cash from investing for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high TTM cash from investing is $285.94M

What is Supernus Pharmaceuticals, Inc. TTM cash from investing year-on-year change?

Over the past year, SUPN TTM cash from investing has changed by +$48.63M (+36.96%)
On this page